Responses to parliamentary questions
Question from Deputy Niamh Smyth - PQ 53801-26
Deputy Smyth asked for an update on the HSE's consideration of Skyclarys for the treatment of Friedreich's ataxia. Read the HSE response.
From: Communications and public affairs
Published: July 2026
Updated: August 2026
Documents
Summary
To ask the Minister for Health if she will provide an update on the HSE's consideration of Skyclarys for the treatment of Friedreich's ataxia; the reason the drug was not included on the agenda of the HSE Drugs Group meeting of 14 July 2026; if she will confirm when a decision is expected; and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it